| 1 | 6W2A |
Replicase polyprotein 1a |
Severe acute respiratory syndrome coronavirus (SARS-CoV) |
P0C6U8 |
(1S,2S)-2-[(N-{[(4,4-difluorocyclohexyl)methoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
VDJ |
 |
SHOW |
| 2 | 6W2A |
Replicase polyprotein 1a |
Severe acute respiratory syndrome coronavirus (SARS-CoV) |
P0C6U8 |
(1S,2S)-2-[(N-{[(4,4-difluorocyclohexyl)methoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
QYS |
|
SHOW |
| 3 | 6XHL |
Replicase polyprotein 1a |
Severe acute respiratory syndrome coronavirus (SARS-CoV) |
P0C6U8 |
(3S)-3-[(2S)-2-[(4-methoxy-1H-indol-2-yl)formamido]-4-methylpentanamido]-2-oxo-4-[(3S)-2-oxopyrrolidin-3-yl]butyl 2-cyanobenzoate |
V2M |
 |
SHOW |
| 4 | 6XHN |
Replicase polyprotein 1a |
Severe acute respiratory syndrome coronavirus (SARS-CoV) |
P0C6U8 |
(3S)-3-[(2S)-2-[(4-methoxy-1H-indol-2-yl)formamido]-4-methylpentanamido]-2-oxo-4-[(3S)-2-oxopyrrolidin-3-yl]butyl 2-cyanobenzoate |
V3D |
|
SHOW |
| 5 | 3VB4 |
Replicase polyprotein 1a |
Severe acute respiratory syndrome coronavirus (SARS-CoV) |
P0C6U8 |
B4Z inhibitor |
0JU |
 |
SHOW |
| 6 | 3VB5 |
Replicase polyprotein 1a |
Severe acute respiratory syndrome coronavirus (SARS-CoV) |
P0C6U8 |
C4Z inhibitor |
0JU |
 |
SHOW |
| 7 | 3VB6 |
Replicase polyprotein 1a |
Severe acute respiratory syndrome coronavirus (SARS-CoV) |
P0C6U8 |
C6Z inhibitor |
0JU |
 |
SHOW |
| 8 | 3SN8 |
Replicase polyprotein 1a |
Severe acute respiratory syndrome coronavirus (SARS-CoV) |
P0C6U8 |
Cm-FF-H |
S89 |
 |
SHOW |
| 9 | 6XHO |
Replicase polyprotein 1a |
Severe acute respiratory syndrome coronavirus (SARS-CoV) |
P0C6U8 |
ethyl (2E,4S)-4-{[N-(4-methoxy-1H-indole-2-carbonyl)-L-leucyl]amino}-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate |
V34 |
 |
SHOW |
| 10 | 3VB7 |
Replicase polyprotein 1a |
Severe acute respiratory syndrome coronavirus (SARS-CoV) |
P0C6U8 |
M4Z inhibitor |
0JU |
 |
SHOW |